Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors
Molecules · 28.02.2025 · 30 (5) · 1105
DOI: 10.3390/molecules30051105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.02.2025. Verfasst von Manal M Kandeel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Indoles, Drug Design, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STDF-RSG, Egypt.
Abstract (Originalsprache)
A series of indolinone-based derivatives were designed and synthesized using the hybrid pharmacophoric design approach as cytotoxic kinase inhibitors. The cytotoxic effects of the designed molecules were tested against MCF-7 and HepG-2 cell lines. Compounds 9 and 20 were the most cytotoxic, with IC50 values against HepG-2 and MCF-7 cells ranging from 2.53 to 7.54 µM. Additionally, compounds 9 and 20 were also found to be slightly more cytotoxic than indirubin with 2.2–2.7-fold higher cytotoxicity with HepG-2 cells. CDK-2 and CDK-4 kinase enzyme inhibition assay showed that compound 9 had a higher inhibitory effect (4.8-fold) than indirubin against CDK-2 and comparable inhibition against CDK-4. Moreover, compound 20 displayed nanomolar inhibitory action against both EGFR kinase and VFGFR-2 enzyme, which were around 8.8- and 5.4-fold higher than the IC50 values of indirubin. Compounds 9 and 20 induced cell cycle arrest at the G1 phase on HepG2 cells. The levels of the key apoptotic proteins assessed revealed elevated levels of the Bax/Bcl-2 ratio, which in turn initiated the caspase3/7 cascade that led to the activation of both intrinsic and extrinsic apoptotic pathways. The cell cycle inhibitory proteins p53 and p21 were significantly upregulated upon treatment with compounds 9 and 20. The docking results revealed that compound 9 exhibits stronger binding affinity to CDK-2 than indirubin, and compound 20 showed a similar binding mode to sorafenib with VEGFR-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Egyptian Russian University, Cairo 11829, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
ORCID-Profile: Mohamed Kamal AbdElhameid, Mohamed Adel, Muhammad Y Al-Shorbagy, Ahmed T Negmeldin
Förderung
- STDF-RSG, Egypt
Zitieren
APA
Kandeel, M. M., AbdElhameid, M. K., Adel, M., Al-Shorbagy, M. Y., & Negmeldin, A. T. (2025). Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors. Molecules, 30(5), 1105. https://doi.org/10.3390/molecules30051105
Vancouver
Kandeel MM, AbdElhameid MK, Adel M, Al-Shorbagy MY, Negmeldin AT. Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors. Molecules. 2025;30(5):1105. doi:10.3390/molecules30051105
BibTeX
@article{Kandeel2025,
author = {Kandeel, Manal M and AbdElhameid, Mohamed Kamal and Adel, Mohamed and Al-Shorbagy, Muhammad Y and Negmeldin, Ahmed T},
title = {Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors},
journal = {Molecules},
year = {2025},
volume = {30},
number = {5},
pages = {1105},
doi = {10.3390/molecules30051105}
}
EUVIMED